166 related articles for article (PubMed ID: 35979255)
1. The Effect and Mechanism of Curcumin Combined with Carboplatin Chemotherapy Promoting on Apoptosis of Lung Cancer HCC827 Cells.
Huang L; He X; Zuo X
J Immunol Res; 2022; 2022():1932692. PubMed ID: 35979255
[TBL] [Abstract][Full Text] [Related]
2. [FOXC1 Knockdown Reverses Gefitinib Resistance in Non-small Cell Lung Cancer].
Peng C; Li P; Yang M; Chen D; Huang Y
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):538-547. PubMed ID: 34334155
[TBL] [Abstract][Full Text] [Related]
3. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
4. Curcumin inhibits the growth via Wnt/β-catenin pathway in non-small-cell lung cancer cells.
Wang JY; Wang X; Wang XJ; Zheng BZ; Wang Y; Wang X; Liang B
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7492-7499. PubMed ID: 30468498
[TBL] [Abstract][Full Text] [Related]
5. Curcumin Enhances the Anti-Cancer Efficacy of CDK4/6 Inhibitors in Prostate Cancer.
Zhao H; Ding R; Han J
Arch Esp Urol; 2024 Jan; 77(1):57-66. PubMed ID: 38374014
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the effects of curcumin nano-chitosan on miR-221 and miR-222 expression and Wnt/β-catenin pathways in MCF-7, MDA-MB-231 and SKBR3 cell lines.
Eslaminejad T; Nematollahi-Mahani SN; Sargazi ML; Ansari M; Mirzaie V
Diagn Pathol; 2024 Feb; 19(1):35. PubMed ID: 38365810
[TBL] [Abstract][Full Text] [Related]
7. Quinacrine and curcumin synergistically increased the breast cancer stem cells death by inhibiting ABCG2 and modulating DNA damage repair pathway.
Nayak D; Tripathi N; Kathuria D; Siddharth S; Nayak A; Bharatam PV; Kundu C
Int J Biochem Cell Biol; 2020 Feb; 119():105682. PubMed ID: 31877386
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin.
Chung LY; Tang SJ; Wu YC; Sun GH; Liu HY; Sun KH
Oncotarget; 2015 Mar; 6(7):4936-52. PubMed ID: 25669973
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of MALAT1 induced osimertinib resistance in HCC827 lung cancer cells].
Kang XH; Gao YY; Wang Y; Cui YH; Zhao KL; Kou WZ; Miao ZH; Cao F; Gong YB
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):257-262. PubMed ID: 31014050
[No Abstract] [Full Text] [Related]
10. Curcumin sensitizes carboplatin treatment in triple negative breast cancer through reactive oxygen species induced DNA repair pathway.
Wang G; Duan P; Wei Z; Liu F
Mol Biol Rep; 2022 Apr; 49(4):3259-3270. PubMed ID: 35076853
[TBL] [Abstract][Full Text] [Related]
11. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.
Yallapu MM; Khan S; Maher DM; Ebeling MC; Sundram V; Chauhan N; Ganju A; Balakrishna S; Gupta BK; Zafar N; Jaggi M; Chauhan SC
Biomaterials; 2014 Oct; 35(30):8635-48. PubMed ID: 25028336
[TBL] [Abstract][Full Text] [Related]
12. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
[TBL] [Abstract][Full Text] [Related]
13. β-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells.
Yu W; Li L; Zheng F; Yang W; Zhao S; Tian C; Yin W; Chen Y; Guo W; Zou L; Deng W
Cell Physiol Biochem; 2017; 44(2):467-478. PubMed ID: 29141249
[TBL] [Abstract][Full Text] [Related]
14. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
15. Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species.
Sankpal UT; Nagaraju GP; Gottipolu SR; Hurtado M; Jordan CG; Simecka JW; Shoji M; El-Rayes B; Basha R
Oncotarget; 2016 Jan; 7(3):3186-200. PubMed ID: 26672603
[TBL] [Abstract][Full Text] [Related]
16. LHX6 Affects Erlotinib Resistance and Migration of
Wang Q; Liao J; He Z; Su Y; Lin D; Xu L; Xu H; Lin J
Onco Targets Ther; 2020; 13():10983-10994. PubMed ID: 33149613
[TBL] [Abstract][Full Text] [Related]
17. [Curcumin induces human lens epithelial cell apoptosis and cell cycle arrest by inhibiting Wnt/β-catenin signaling pathway].
Zhu M; Cui S; Hao Z; Wang W; Yang Q; Chen C; Wang J; Zhou Q
Nan Fang Yi Ke Da Xue Xue Bao; 2021 May; 41(5):722-728. PubMed ID: 34134960
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
Tang Y; Berlind J; Mavila N
Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
[TBL] [Abstract][Full Text] [Related]
19. Curcumin induces apoptotic cell death via Oct4 inhibition and GSK-3β activation in NCCIT cells.
Yun JH; Park YG; Lee KM; Kim J; Nho CW
Mol Nutr Food Res; 2015 Jun; 59(6):1053-62. PubMed ID: 25755051
[TBL] [Abstract][Full Text] [Related]
20. PEBP4 enhanced HCC827 cell proliferation and invasion ability and inhibited apoptosis.
Yu G; Shen Z; Chen G; Teng X; Hu Y; Huang B
Tumour Biol; 2013 Feb; 34(1):91-8. PubMed ID: 22983920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
